SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-006761
Filing Date
2021-03-25
Accepted
2021-03-25 07:01:01
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm 20-F 2262973
2 ex2-7.htm EX-2.7 56315
3 ex12-1.htm EX-12.1 17033
4 ex12-2.htm EX-12.2 16713
5 ex13-1.htm EX-13.1 10385
6 ex15-1.htm EX-15.1 4479
7 form20-f_02.jpg GRAPHIC 19842
8 logo_001.jpg GRAPHIC 6104
9 form20-f_001.jpg GRAPHIC 111393
  Complete submission text file 0001493152-21-006761.txt   6045439

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE vblt-20201231.xml EX-101.INS 765647
11 XBRL SCHEMA FILE vblt-20201231.xsd EX-101.SCH 43674
12 XBRL CALCULATION FILE vblt-20201231_cal.xml EX-101.CAL 58058
13 XBRL DEFINITION FILE vblt-20201231_def.xml EX-101.DEF 172932
14 XBRL LABEL FILE vblt-20201231_lab.xml EX-101.LAB 339135
15 XBRL PRESENTATION FILE vblt-20201231_pre.xml EX-101.PRE 280089
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 21770088
SIC: 2834 Pharmaceutical Preparations